Evaluating the measures taken to contain a Candida auris outbreak in a tertiary care hospital in South India: an outbreak investigational study
Open Access
- 6 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 21 (1), 1-10
- https://doi.org/10.1186/s12879-021-06131-6
Abstract
Candida auris infections are an emerging global threat with poor clinical outcome, high mortality rate, high transmission rate and outbreak potential. The objective of this work is to describe a multidisciplinary approach towards the investigation and containment of a Candida auris outbreak and the preventive measures adopted in a resource limited setting. This outbreak investigational study was conducted at a 1300-bedded tertiary care academic hospital in South India. The study included 15 adult inpatients with laboratory confirmed Candida auris isolates. The outbreak cluster was identified in adult patients admitted from September 2017 to 2019. The system response consisted of a critical alert system for laboratory confirmed Candida auris infection and multidisciplinary ‘Candida auris care team’ for patient management. The team implemented stringent Infection Prevention and Control (IPC) measures including patient cohorting, standardized therapy and decolonization, staff training, prospective surveillance and introduction of Candida auris specific care bundle. Two outbreak clusters were identified; first cluster occurring between October and November 2017 and the second cluster in May 2018. The cohorts consisted of 7 and 8 Candida auris positive patients in the first and second waves of the outbreak respectively with a total survival rate of 93% (14/15). Deployment of containment measures led to gradual decline in the incidence of adult Candida auris positive cases and prevented further cluster formation. The sustained implementation of guideline and evidence-based IPC measures and training of healthcare workers for improving awareness on systematically following standardized protocols of Candida auris related IPC practices successfully contained Candida auris outbreaks at our hospital. This demonstrates the feasibility of establishing a multidisciplinary model and bundling of practices for preventing Candida auris outbreaks in a Low- and Middle-income country.This publication has 22 references indexed in Scilit:
- Clinical Outcomes of Patients Treated for Candida auris Infections in a Multisite Health System, Illinois, USAEmerging Infectious Diseases, 2020
- Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida aurisScientific Reports, 2020
- Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017Infection Control & Hospital Epidemiology, 2019
- Candida auris outbreak: Mortality, interventions and cost of sustaining controlJournal of Infection, 2019
- Identification of Drug Resistant Candida aurisFrontiers in Microbiology, 2019
- Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patientsExpert Review of Anti-infective Therapy, 2019
- Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida aurisJournal of Intensive Care, 2018
- Global and Multi-National Prevalence of Fungal Diseases—Estimate PrecisionJournal of Fungi, 2017
- Invasive Infections with Multidrug-Resistant Yeast Candida auris, ColombiaEmerging Infectious Diseases, 2017
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospitalMicrobiology and Immunology, 2009